Sevelamer is cost effective versus calcium carbonate for the first-line treatment of hyperphosphatemia in new patients to hemodialysis: a patient-level economic evaluation of the INDEPENDENT- HD study. J Nephrol. 2015 Oct;28(5):593-602.
awith associated gross ingredient costs of £440,248; and for sevelamer preparations (hydrochloride and carbonate) there were 6,163 prescriptions at a cost of £979,213. 以£440,248的伴生的总成份费用; 并且为sevelamer准备 (氯化物和碳酸盐) 有6,163张处方在£979,213的一费用。[translate...
Sevelamer is cost effective versus cal- cium carbonate for the first-line treatment of hyperphosphatemia in new patients to hemodialysis: a patient-level economic evaluation of the INDEPENDENT-HD study. J Nephrol 2015; 28: 593-602Erratum to: Sevelamer is cost effective versus calcium carbonate ...
Sevelamer is cost effective ver- sus calcium carbonate for the first-line treatment ofhyperphosphatemi- a in new patients to hemodialysis: a patient-level economic evaluation of the 1NDEPENDENT-HD study[J]. Journal of nephrology, 2015, 28 (5): 593-602....
The objective of this study was to determine the cost-effectiveness of sevelamer versus calcium carbonate for patients new to HD, using patient-level data from the INDEPENDENT study. STUDY DESIGN: Cost-effectiveness analysis. SETTING AND POPULATION: Adult patients new to HD in Italy. MODEL, ...
COST IMPLICATIONS OF SWITCHING FROM SEVELAMER TO LANTHANUM CARBONATE WITHIN A BUNDLED REIMBURSEMENT SCENARIOdoi:10.1053/j.ajkd.2013.02.157NoneAmerican Journal of Kidney Diseases
Publication » PUK20 THE COST-EFFECTIVENESS OF LANTHANUM CARBONATE VS. SEVELAMER HYDROCHLORIDE IN PATIENTS WITH END-STAGE RENAL DISEASE.doi:10.1016/S1098-3015(11)73036-4Park, HRascati, KLKeith, MSHodgkins, PSSmyth, MDGoldsmith, DAkehurst, RL...
The goal of our study is to use a wider range of clinical data to achieve a more contemporary and robust cost-effectiveness analysis. We used a Markov model to estimate the lifetime costs and quality-adjusted life years (QALYs) gained for treatment with sevelamer versus calcium carbonate. ...
REAL-WORLD DOSE EQUIVALENCY AND COST COMPARISONS OF CONVERSIONS BETWEEN SEVELAMER HYDROCHLORIDE/CARBONATE AND LANTHANUM CARBONATE MONOTHERAPIESdoi:10.1053/j.ajkd.2014.01.206SDOSAmerican Journal of Kidney Diseases
PUK25. A Spanish Cost-Effectiveness Analysis Of Sevelamer Versus Calcium Carbonate In Nondialysis-Dependent Chronic Kidney Disease (Ckd) PatientsBackground: Evaluate the impact of ProFiL, a training-and-communication network program in nephrology, on pharmacists' knowledge and clinical competencies, ...